Skip to main content
WELLBIOTEC CO.,LTD logo

WELLBIOTEC CO.,LTD — Investor Relations & Filings

Ticker · 010600 ISIN · KR7010600005 KO Manufacturing
Open in API
Filings indexed 423 across all filing types
Latest filing 2022-12-29 M&A Activity
Country KR South Korea
Listing KO 010600

About WELLBIOTEC CO.,LTD

http://www.wellbiotec.com/?language=eng

WELLBIOTEC CO.,LTD. is a diversified company with operations in several sectors. Its business activities include the development and distribution of biopharmaceutical products, such as specialized medicines, health functional foods, and diagnostic kits. The company is also involved in the electric vehicle (EV) charging business and logistics. Additionally, it manufactures and sells leather products for fashion goods, including shoes and handbags.

Recent filings

Filing Released Lang Actions
[기재정정]투자판단관련주요경영사항
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Wellbiotech) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Major Management Matter' (주요경영사항) concerning a stock purchase agreement and change in the largest shareholder. Since this is a specific regulatory disclosure regarding corporate management and material changes that does not fit into specialized categories like M&A (which usually refers to company-level mergers) or Share Issues, it is best classified as a general Regulatory Filing (RNS).
2022-12-29 Korean
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding the issuance of convertible bonds (전환사채권 발행결정) and specifically details a correction (정정신고) to the terms of the issuance, such as maturity dates and payment schedules. In the context of Korean regulatory filings (DART), this type of document is a formal disclosure of capital structure changes and financing activities. Since it is a specific regulatory filing regarding financing, it falls under the 'Capital/Financing Update' category.
2022-12-23 Korean
[기재정정]타법인주식및출자증권처분결정
M&A Activity Classification · 100% confidence The document is a regulatory filing from a Korean company (Well Biotech) regarding the cancellation of a previously announced disposal of shares in another company (Biogenics Korea). This is a formal disclosure of a material event related to corporate strategy and asset management. Since it involves the cancellation of a transaction (M&A/disposal activity) and is filed as a formal regulatory disclosure, it fits best under 'Regulatory Filings' (RNS) as it is a specific corporate announcement that does not fit into the more specialized categories like M&A (which usually implies an active deal) or Share Issue/Capital Change.
2022-12-21 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and the purpose of holding (influencing management) by a major shareholder (Daeyang D&I) in a listed company (Well Biotech). This type of filing is specifically categorized as a Major Shareholding Notification.
2022-12-12 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal regulatory filing from a Korean company (Well Biotech) regarding the 'Resolution to Convene a General Meeting of Shareholders' (주주총회소집결의). It details the agenda for an Extraordinary General Meeting, including the appointment of directors, auditors, and changes to business objectives. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting agendas and voting items.
2022-12-07 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for WellBiotec Co., Ltd. It includes details about the meeting date, location, agenda items (such as board appointments and articles of incorporation changes), and information regarding electronic voting. This document is a formal proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and request their participation/votes. It fits the definition of a Proxy Solicitation & Information Statement (PSI).
2022-12-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.